Phlow gets $354 mln U.S. funding to ensure drug supply amid COVID-19 pandemic

by Reuters
Tuesday, 19 May 2020 11:51 GMT

(Corrects typo in second paragraph, adds dropped word in headline)

May 19 (Reuters) - U.S. drug manufacturer Phlow said on Tuesday it had received $354 million from the government to speed up the manufacturing of drugs being tested and used to fight the new coronavirus.

The company said it would also use the grant to advance the production of medicines at risk of shortage. (https://prn.to/36eitka) (Reporting by Saumya Sibi Joseph in Bengaluru; Editing by Saumyadeb Chakrabarty)

Our Standards: The Thomson Reuters Trust Principles.